Abstract
Hydroxychloroquine (HCQ) is a drug being increasingly used in the treatment of various autoimmune disorders. Retinal toxicity is a complication of prolonged use causing permanent visual loss in patients receiving HCQ. We report a case of HCQ retinopathy who received the drug for 35 years for rheumatoid arthritis. She had never been advised for ophthalmologic evaluation before. Interprofessional collaboration will help in the early detection of retinal damage, treatment with alternate drugs, and prevention of permanent retinal damage.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
